H19 and cancer: For instance, the well-known lncRNA H19 displays aberrant promoter hypomethylation in many different cancer-types, including bladder cancer (Takai et al., 2001), colorectal cancer (Tian et al., 2012), and oral squamous cell carcinoma (Lee et al., 2021).